🌿 30+ Years of Documented Use · Originally Registered in Kazakhstan, 1993

The Original Antibiotic-Resistant Probiotic Supported by 30+ Years of Clinical Evidence

Maxilin Share the Love promotional image featuring a woman holding a probiotic sachet alongside Maxilin packaging

Built on Lactobacillus acidophilus strain 2585 — a named, patented strain, not a generic species. Available as a fermented liquid and as a lyophilised, microencapsulated dry sachet. 30+ years of documented clinical use, zero reported adverse effects across 60,000+ users, and every record published in full.

2585
Patented Acidophilus Strain
1993
First Registered
60,000+
Users · Zero Side Effects
Read the Clinical Research Why Maxilin Is Different
Eurasian Patent No. 014227 B1 — Strain 2585 Pharmacological Commission, Ministry of Health — Protocol No. 12, 1993 FSSAI Central License – India FDA-Registered GMP Facility No Contraindications Documented

Fungal disease deserves more attention

The shared images highlight the often-overlooked burden of fungal disease. The CDC reports the following approximate annual figures for the United States:

Associated deaths
7,300
Associated hospitalisations
130,000
Outpatient visits
13 million
Estimated national cost (USD)
$19 billion

These estimates concern fungal diseases overall. Read the CDC figures and context (opens in a new tab).

Where Maxilin fits: Research on Lactobacillus acidophilus strain 2585 reported antagonistic activity against Candida albicans (a fungus) and the bacteria Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coli. Activity was strongest against Candida among the four organisms tested. Explore the strain-specific findings and limitations.

Illustrated pathway showing how Maxilin strain 2585 and inulin support survival through the stomach and colonization in the small intestine

Maxilin & Candida: understanding the mechanisms

How might beneficial bacteria interact with Candida albicans? The illustration below introduces three mechanisms explored in probiotic research; a fourth involves the body's local immune response.

Maxilin and Candida infographic illustrating competition for space and nutrients, changes in acidity, and production of antimicrobial substances. Explanations and evidence limitations follow below.
Supplied educational illustration, not proof of a treatment effect. View full-size image (opens in a new tab).
  1. Competition for nutrients & space

    Some beneficial bacteria compete for nutrients and attachment sites on mucosal surfaces. This may make it harder for Candida to attach and establish a biofilm.

  2. Changes in acidity (pH)

    Organic acids produced by some probiotic bacteria can affect Candida growth and its transition to a filamentous form in laboratory conditions. Effects depend on the strain and environment; acidity alone does not prevent vaginal candidiasis.

  3. Production of antimicrobial substances

    Depending on the strain, bacteria can produce compounds such as hydrogen peroxide, antimicrobial peptides and organic acids. Researchers study how these substances may inhibit fungal growth.

  4. Interaction with local immunity

    Some probiotic strains are studied for their effects on mucosal immune responses, including IgA and inflammatory signalling. These effects are strain-specific, not a guaranteed Candida treatment benefit.

What this means for Maxilin: These are research mechanisms, not confirmation that Maxilin delivers every effect shown in the illustration. Findings about other Lactobacillus or Bifidobacterium strains cannot automatically be applied to Maxilin's L. acidophilus strain 2585. Read the strain-specific research and its limitations.

Important: Maxilin is not presented here as a proven treatment for Candida infection or a replacement for prescribed antifungal medication. The CDC's vaginal candidiasis guidance states that substantial evidence does not support probiotics as treatment. If you suspect an infection or have persistent symptoms, speak with a qualified healthcare professional.

Most Probiotics Don't Survive Your Gut — Or Your Antibiotics. Maxilin Does Both.

Conventional probiotics are synthetically manufactured, destroyed by stomach acid, and wiped out during antibiotic courses. Maxilin was engineered over decades to solve all three problems.

01

Naturally sourced — a named strain, not a generic species

Most commercial probiotics are laboratory-grown strains selected for ease of cultivation, and many name only a species. Maxilin names its strain: L. acidophilus 2585, described in the lineage records as isolated from a naturally occurring source rather than selected in a laboratory. See the provenance record.

02

Antibiotic-Resistant — works during your prescription

Confirmed resistant to streptomycin, neomycin, monomycin, chloramphenicol, and gentamicin. Every other probiotic is destroyed by antibiotics.

03

Lyophilized — arrives live in the intestine

Lyophilized means freeze-dried. It refers to a dehydration process where a product is first frozen and then placed in a vacuum so the water (or other solvent) turns directly from ice into vapor without ever passing through a liquid state. 2024 lab testing confirmed 20 billion CFU delivered live — zero coliform contamination. Most probiotics lose the majority of bacteria to stomach acid.

A Named Strain, A Granted Patent, And A Paper Trail You Can Check

"Lactobacillus acidophilus" is a species containing thousands of strains that behave differently. Everything documented on this site belongs to one of them: strain 2585.

01

Eurasian Patent No. 014227 B1

"Method for producing the fermented-milk product 'Maxilin' and method of correcting microflora in the organism of humans and animals." Filed 15 December 2006, granted 29 October 2010 to Grigory Ivanovich Miroshnikov, valid across nine Eurasian convention states. Kazakhstan National Patent No. 14850 was filed 19 March 2004. A patent establishes novelty and ownership — not clinical efficacy.

02

Approved by the Pharmacological Commission

The original formulation was registered as a natural medicine by the Pharmacological Commission of the Kazakh Ministry of Health under Protocol No. 12 on 19 February 1993, with two clinical-use instructions approved in 1993 and 1994. In 2013 the Association of Nutritionists, Gastroenterologists and Endoscopists of Kazakhstan (ANGEK) reaffirmed the dosing protocol.

03

Named researchers, named institutions

The clinical-use instructions were authored by G. A. Gulyaeva and T. A. Kharitonova at the Alma-Ata State Medical Institute. The research was conducted at the Kazakh National Medical University and recorded at the Central Clinical Hospital, the Republican Polyclinic and the Institute of Pediatrics in Almaty. One publication is independently indexed on PubMed as PMID 10961107.

Two Industrial Steps That Get The Bacteria Past Your Stomach Alive

Putting live bacteria in a sachet is easy. Keeping them alive on a shelf, and then alive through gastric acid, is where most products fail. BIODEP solves each problem separately.

01

Lyophilization (freeze-drying)

BIODEP takes the live Lactobacillus acidophilus (strain 2585) culture after liquid fermentation and subjects it to rapid industrial freeze-drying. This process removes moisture under a vacuum, turning the liquid bacteria into a highly concentrated, shelf-stable dry powder without killing the live cells.

02

Microencapsulation (coating)

Once dried, BIODEP applies its proprietary multi-layer embedded micro-coating technology (ProCap™) to the powder. This microscopic outer shield insulates the individual bacterial cells, ensuring they can withstand ambient moisture and survive the highly acidic passage through the human stomach.

What this is: process information supplied by the manufacturer. It describes how the dry product is made and is not itself a clinical finding — viable-CFU survival through simulated gastric transit has not been independently assayed for the current sachet. See the full manufacturing detail.

Maxilin is a Synbiotic — Bacteria and Their Food

A synbiotic is a probiotic plus a prebiotic: living bacteria together with the food they need to survive and thrive. Most products give you only the bacteria — Maxilin gives you both.

🦠

Probiotic

The living bacteria — naturally-sourced L. acidophilus 2585 — that restore and rebalance your gut microflora.

🌾

+ Prebiotic (Inulin)

The bacteria's food. Inulin passes intact through the small intestine and reaches the large intestine, where it feeds the bacteria.

= Synbiotic

Bacteria that stay viable far longer — so they actually do their job, and you can pause the course for a time.

Otherwise, there is no point in swallowing trillions of cells: if there is no food for them, they live a very short time and never do their job. The inulin in Maxilin is exactly that food — keeping the bacteria alive long enough to restore your gut.

30 Years of Verified Clinical Records

Every milestone is supported by signed clinical acts, pharmacological approvals, patent certificates, and laboratory test reports.

19 Feb 1993

Registered as a natural medicine — Kazakhstan

Approved by the Pharmacological Commission (Protocol No. 12). Pure culture of acidophilic bacteria, strains 2585–17666.

Apr–Jun 1993

First supervised clinical use — dysbacteriosis

1st Polyclinic Association, Almaty. Normalised digestion, improved wellbeing, significant reduction in lactose-negative bacilli.

Aug–Oct 1994

Gynaecology trial — Republican Military Polyclinic

Genital infections and dysbacteriosis. Doderlein bacilli (healthy flora) appeared in smears within 5–7 days.

Oct–Dec 1994

Paediatric trial — Institute of Pediatrics, Almaty

Intestinal dysbacteriosis, chronic colitis, secondary malabsorption in children.

Oct 2010

Eurasian Patent No. 014227 granted

Method for obtaining Maxilin and correcting microflora in humans and animals. Valid across 9 Eurasian convention countries.

Sep 2024

Independent lab testing — Almaty Technological University

Test Report No. 798. 20 billion CFU lactic acid microorganisms confirmed. Zero coliforms. See the evidence records.

Dec 2025

FSSAI Central License granted — India

License No. 12725999000778. EnergyMax Global Private Limited. Grand opening April 2026.

How maXilin™ Compares

FactormaXilin™Standard Probiotic
Source✓ Natural — L. acidophilus 2585✗ Synthetically manufactured
Probiotic + prebiotic✓ Synbiotic — includes inulin to feed the bacteria✗ Bacteria only; no built-in food source
Antibiotic resistance✓ Survives all major antibiotic classes✗ Destroyed by antibiotics
Stomach survival✓ Lyophilized (freeze-dried); confirmed live delivery✗ Majority perish in stomach acid
Clinical documentation✓ 30+ years of signed acts, Eurasian PatentGeneral literature; limited clinical acts
Age suitability✓ Newborn to elderly; no contraindicationsOften age-restricted or untested in infants
Dietary profile✓ Vegan · dairy-free · GMO-free · lactose-freeVaries widely
Side effects✓ Zero across 60,000+ users over 7 yearsGI discomfort reported in some users

Documented Health Support Areas

Gut Microbiome Restoration

Normalises microflora, addresses dysbacteriosis and SIBO, reduces bloating, regulates peristalsis. Clinically demonstrated since 1993.

Immune System Support

70% of immune function resides in the gut. Restoring microbiota integrity supports the body's natural defence processes.

Women's Health

1994 clinical trial showed resolution of genital infection symptoms and restoration of normal vaginal flora within 5–7 days.

Children — From Birth

Supervised paediatric use since 1994. Dosing from newborns through adults. No contraindications in 30+ years.

Antibiotic Compatibility

Survives antibiotic treatment. Maintains gut integrity during a course and may enhance antibiotic efficacy.

Antimicrobial Activity

Significant suppression of Candida, Pseudomonas aeruginosa, S. aureus, and E. coli within 3–4 days.

Gut–Brain Axis

Users report improved clarity and energy as gut integrity is restored through the gut-brain connection.

Cellular Health

Supports the body's natural clearance of intestinal toxins. Improved nutrient absorption supports cellular regeneration.

Interview with Grigory Ivanovich Miroshnikov — Creator of Maxilin

Microbiologist, former military officer, and Chernobyl responder. In this rare interview, Grigory Ivanovich tells the full story — how Maxilin was born, how it helped him personally recover from radiation sickness, and why prevention is the core mission.

🎙️ Interview conducted by Aslambek Kellys, EnergyMax Partner

🌱 THE ORIGIN — Tokyo, 1908

At a Tokyo microbiology symposium, Galina Maksimovna — a Candidate of Biological Sciences — responded to a Japanese presentation on a dangerous new microbe by declaring: "In our country, we will create a microbe that will defeat yours." The hall applauded. That challenge launched decades of work.

🔬 THE STRAIN — From Nature Itself

One source was animal biological material. Another came from human neonatal meconium — the first stool of a newborn, containing the body's natural founding microflora. Isolated, adapted, and refined over decades into what became L. acidophilus 2585.

⚠️ CHERNOBYL — Personal Recovery

In early 1987, Grigory Ivanovich was deployed to the Chernobyl disaster zone for three months and developed radiation sickness. He was prescribed Maxilin alongside other medications. "It helped me restore my gastrointestinal tract," he says. "What mattered was that Maxilin helped me."

💬 HIS FINAL MESSAGE

"Use Maxilin as a path to health, as a path to a healthy lifestyle. Use it, and everything will be well. There is nothing better than prevention."

— Grigory Ivanovich Miroshnikov, Microbiologist & Creator of Maxilin

📋 Q&A with the Inventor — Grigory Ivanovich Miroshnikov

Q — Was the strain genetically modified?
No. There was no insertion of one bacterium into another. The strains — one from a newborn lamb, one from human neonatal meconium — were of the same type. They grow and live naturally on their own.
Q — Why was the bacterium adapted to antibiotics?
When people take antibiotics, beneficial gut bacteria are destroyed along with harmful ones. The goal was to create a strain that survives antibiotic treatment — so patients could take a course without completely destroying their microflora. The adaptation process took approximately ten years.
Q — What did clinical trials show?
A Kazakh gastroenterology professor tested Maxilin on 60 people over a 14-day course — using Maxilin alone, with no other medicines. Microflora samples were taken before and after. According to the professor, the difference in intestinal microflora was enormous. Demand quickly outpaced what could be supplied.
Q — What are the storage requirements?
Liquid form: 2–8°C during transport. Official shelf life 15 days (living culture may remain active longer).
Dry / capsule form: 20–25°C, low humidity. Shelf life up to 2 years.
Q — How should it be taken after the first course?
14 days on → ~10 days off → repeat 14-day course. This allows the bacteria to establish properly in the intestine. Ongoing preventive use is also appropriate for long-term gut maintenance.
Q — Is it a medicine or a supplement?
In Ireland and across the EU, Maxilin is sold and regulated as a food supplement, not as a medicine. Although its 1993 registration in Kazakhstan as a natural preparation forms part of its documented history, customers in Ireland and the EU should understand and use Maxilin solely as a food supplement.
Q — How does it work against harmful organisms?
Maxilin creates an intestinal environment in which harmful microorganisms cannot reproduce easily — including parasites, pathogens, and Candida. It does not attack directly; it restructures the gut environment so harmful organisms cannot thrive.
Q — Dosage guidance?
Adults (liquid): 50–100ml, 3× daily, 30 minutes before meals.
Children: Smaller doses depending on age.
Infants: Contents of capsule opened and mixed before use.
Capsules (adults): Take before meals. Also suitable for topical/cosmetic application.
1908
Scientific challenge issued in Tokyo
1980s
Development completed; military use began
1987
Used by Chernobyl responders
14 days
Documented microflora restoration course
0
Side effects reported by inventor

Gut Education Video Series

A curated playlist explaining how gut health works, why microbiota integrity matters, and how Maxilin supports the body. Watch the full series below.

Free Guide: The Strength of the Gut MicrobiomeRead the free 24-page English guide online or download the PDF. Weekly Microbiome Code Email SeriesDaily science-backed lessons on strain 2585, antibiotic recovery, and gut resilience delivered to your inbox.

📺 View the full Gut Education playlist on YouTube

Real User Results

Photos sent to us by members of the Maxilin community, published as we received them.

⚠️ No health claims are made using Maxilin

Maxilin is a food supplement. It is not a medicine and is not intended to diagnose, treat, cure or prevent any disease or condition. Nothing on this page should be read as a health claim, a medical outcome, or a promise of any result.

The photos below are personal accounts shared voluntarily by community members. They are published unedited, are not verified by us, are not clinical evidence, and are not medical advice. Any wording that appears inside a photo is the words of the person who sent it, not a claim by Maxilin or EnergyMax Group.

Individual experiences vary and are not representative of what anyone else should expect. Always speak to a qualified healthcare professional about any health concern, and never stop or replace prescribed treatment.

Tap any photo to view it full size. Personal accounts only — no health claims are made using Maxilin.

Experience After Using Maxilin

Watch personal accounts shared by people about their experiences after using Maxilin.

This video shares an individual personal account, not clinical evidence, medical advice, or a promise of results. Individual experiences vary. Maxilin is a food supplement, not a medicine.
This video shares an individual personal account about eye contact and sleep, not clinical evidence, medical advice, or a promise of results. Individual experiences vary. Maxilin is a food supplement, not a medicine.
This video shares Gayle's individual personal account about mobility, not clinical evidence, medical advice, or a promise of results. Individual experiences vary. Maxilin is a food supplement, not a medicine.
A family shares the moment their son says “Daddy” for the first time. This personal account is not clinical evidence, medical advice, or a promise of results, and does not establish that Maxilin caused this milestone. Individual experiences vary. Maxilin is a food supplement, not a medicine.
IN EU Order Now
🇪🇺 Fast shipping